OncLive | Bringing the Global Oncology Community Together

OncLive

Education ▼

Register | Login

Conference Coverage

OncLive INSIGHTS

Stay tuned for our LIVE OncLive News Network coverage straight from the #ASH18 conference floor!

SPECIALTY TOPICS

CURRENTLY VIEWING
All Specialties

Multiple Myeloma

Immuno-Oncology News

Gynecologic Oncology

Gastrointestinal Cancer

Colorectal Cancer

Prostate Cancer

Neoadjuvant HER2+

Latest News

Future of MCL Treatment May Lie in Combinations, CAR T-Cell Therapy

Future of MCL Treatment May Lie in Combinations, CAR T-Cell Therapy

Robert Dean, MD, discusses the promise for new therapies in mantle cell lymphoma. Read More >>

OncFellows Forum

Long-Term Maintenance Olaparib Safe and Effective for Patients With Recurrent Ovarian Cancer

Expert Explains Surgical Considerations in High-Risk Prostate Cancer

Enhanced Education Part of Successful Biosimilar Integration

NY LUNG 2018: More Data Needed on Changing Systemic Therapy in NSCLC

NY LUNG 2018: Biomarkers and Histology Play Key Roles in Frontline Metastatic NSCLC Options

View More Stories >>

top border

View Conference Coverage

2018 Chemotherapy Foundation Symposium

2018 New York Lung Cancers Symposium

2018 State of the Science Summit on Hematologic Malignancies in Clayton

State of the Science Summit on GI Cancers in Newport Beach

2018 ESMO Congress

Dr. Nguyen on Treatment Approaches for Patients With Advanced Ovarian Cancer

Dr. Nguyen on Treatment Approaches for Patients With Advanced Ovarian Cancer

Dr. Feldman on the Future of Durvalumab and Tremilimumab in NSCLC

Dr. Feldman on the Future of Durvalumab and Tremilimumab in NSCLC

Dr. Rugo on Resistance to CDK4/6 Inhibitors in HR+ Breast Cancer

Dr. Rugo on Resistance to CDK4/6 Inhibitors in HR+ Breast Cancer

Dr. Powles on Biomarkers for Immunotherapy in Bladder Cancer

Dr. Lassen Discusses TRK Fusions in Pediatric Patients

Dr. Gorantla on the Impact of the APHINITY Trial in HER2+ Breast Cancer

Dr. Choueiri on Biomarkers in RCC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Additional Targets in NSCLC: BRAF V600E and BRAF Variants

Additional Targets in NSCLC: BRAF V600E and BRAF Variants

Second Generation ALK Inhibitors in NSCLC

Second Generation ALK Inhibitors in NSCLC

Practice-Changing Frontline Treatment of ALK+ NSCLC

Practice-Changing Frontline Treatment of ALK+ NSCLC

Updates in the Treatment of ALK+ and ROS1+ NSCLC

Adjuvant TKI for Early Stage EGFR+ NSCLC

Frontline Chemo and TKI Combination in EGFR+ NSCLC

Promising EGFR Inhibitors in Development for NSCLC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Future Management of Metastatic Colorectal Cancer

Future Management of Metastatic Colorectal Cancer

Emerging Therapy in Metastatic Colorectal Cancer

Emerging Therapy in Metastatic Colorectal Cancer

BEACON Trial: Triplet Therapy in BRAF V600E

BEACON Trial: Triplet Therapy in BRAF V600E

Later Lines of Therapy for Metastatic Colorectal Cancer

Other I-O Approaches to Metastatic Colorectal Cancer

ReDOS Trial: Optimizing Regorafenib Dosing in metastatic Colorectal Cancer

I-O Therapy in mCRC: Ipilimumab + Nivolumab

OncLive houses thousands of videos that provide updates and information.
See more Videos

top border

Featured

Expert Anticipates Cure in Acute Lymphoblastic Leukemia

Elias Jabbour, MD, discussed recent clinical trial results in acute lymphoblastic leukemia, the role of immunotherapy, and the biggest challenges facing the field.

View more >>>

Featured

Dr. Ramchandren on the North American Results of the ECHELON-1 Study in Hodgkin Lymphoma

Radhakrishnan Ramchandren MD, associate professor, Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute, discusses the North American results of the ECHELON-1 study in Hodgkin lymphoma.

View more >>>

Featured Video

ESMO Asia mCRC Guidelines: Insights on Impact and Uptake

ESMO Asia mCRC Guidelines: Insights on Impact and Uptake

ESMO Asia mCRC Guidelines: Insights on Impact and Uptake.View now

Optimal Sequence of Therapies for R/M SCCHN

Optimal Sequence of Therapies for R/M SCCHN.View now

OncLive State of the Science Summit

OncLive SAP

OncLive^® On Air is a podcast of interviews with academic oncologists on their presentations from the OncLive^® State of the Science Summits^TM.

Trending Now

Biomarkers and Histology Play Key Roles in Frontline Metastatic NSCLC Options

Herbst Highlights Next Steps With Immunotherapy in Lung Cancer

More Data Needed on Changing Systemic Therapy in NSCLC

Pharmacy Expert Shares Insights on Ready-to-Use Cytotoxic Drugs

Covering Every Angle of Oncology Practice. Click a cover below, to view more.

Publication Bottom Border

Dermatologists in Cancer Care®

Rapid Reviews in Oncology®

Urologists in Cancer Care

Oncology Business News

Contemporary Radiation Oncology

Oncology Nursing News

Oncology Fellows

Precision Medicine in Oncology

Invited Presentations

Oncology Treatment Pathways®

CURE Rare Cancers-Summer 2017 Issue

HEAL Summer 2017

Extraordinary Healers Vol. 11

Border Publication

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Oncology Nursing News
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
TargetedOnc

OncLive Resources

Articles
Blogs
Conference Coverage
OncLive TV
Peer Exchange
Publications
Specialties
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Forgot Password
Press Releases
Privacy Policy
Terms & Conditions

iTunes

YouTube

Google Plus

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-939-0221

Copyright OncLive 2006-2018
Intellisphere, LLC. All Rights Reserved.

x